Search Results - "Feldman, Paul L."
-
1
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies
Published in PloS one (03-04-2014)“…GPR119 receptor agonists improve glucose metabolism and alter gut hormone profiles in animal models and healthy subjects. We therefore investigated the…”
Get full text
Journal Article -
2
Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes
Published in Journal of medicinal chemistry (27-06-2013)“…The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal…”
Get full text
Journal Article -
3
Insights into the Chemical Discovery of Remifentanil
Published in Anesthesiology (Philadelphia) (01-05-2020)“…Design, Synthesis, and Pharmacological Evaluation of Ultrashort- to Long-acting Opioid Analgetics. By Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster…”
Get full text
Journal Article -
4
A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs
Published in Microbiology spectrum (03-09-2021)“…The toxicity of tenofovir alafenamide (TAF) hemifumarate (HF) was evaluated when administered by continuous subcutaneous (s.c.) infusion via an external…”
Get full text
Journal Article -
5
Nitric Oxide: A New Paradigm for Second Messengers
Published in Journal of medicinal chemistry (01-10-1995)Get full text
Journal Article -
6
Development and Regulatory Challenges for Peptide Therapeutics
Published in International journal of toxicology (01-03-2021)“…There has been an increased interest in and activity for the use of peptide therapeutics to treat a variety of human diseases. The number of peptide drugs…”
Get full text
Journal Article -
7
Quality guidelines for oral drug candidates: dose, solubility and lipophilicity
Published in Drug discovery today (01-10-2016)“…[Display omitted] •Experimental properties of GSK's oral portfolio were compared with marketed drugs.•Properties were dose, solubility and the property…”
Get full text
Journal Article -
8
Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1
Published in Journal of medicinal chemistry (30-11-2006)“…The high expression of MCH in the hypothalamus with the lean hypophagic phenotype coupled with increased resting metabolic rate and resistance to high fat…”
Get full text
Journal Article -
9
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
Published in AIDS research and human retroviruses (01-06-2021)“…The ability to successfully develop a safe and effective vaccine for the prevention of HIV infection has proven challenging. Consequently, alternative…”
Get more information
Journal Article -
10
CNS 7056: a novel ultra-short-acting Benzodiazepine
Published in Anesthesiology (Philadelphia) (01-07-2007)“…A new benzodiazepine derivative, CNS 7056, has been developed to permit a superior sedative profile to current agents, i.e., more predictable fast onset, short…”
Get full text
Journal Article -
11
A Novel One-Pot Synthesis of N-Substituted Thieno[3,2-d]pyrimidin-4(3H)-ones
Published in Heterocycles (31-12-2006)Get full text
Journal Article -
12
Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430: A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates
Published in Organic letters (16-12-1999)“…The stereo- and regioselective synthesis of ultra-short-acting nondepolarizing neuromuscular blocker GW 0430 (5a) is described. Key steps involved the…”
Get full text
Journal Article -
13
Bis- and Mixed-Tetrahydroisoquinolinium Chlorofumarates: New Ultra-Short-Acting Nondepolarizing Neuromuscular Blockers
Published in Journal of medicinal chemistry (28-01-1999)Get full text
Journal Article -
14
An efficient and practical total synthesis of (+)-vincamine from L-aspartic acid
Published in Journal of organic chemistry (01-05-1990)Get full text
Journal Article -
15
Design and Synthesis of Conformationally Constrained Analogs of 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) as Potent Inhibitors of cAMP-Specific Phosphodiesterase
Published in Journal of medicinal chemistry (01-11-1995)“…The synthesis and biological evaluation of cAMP-specific phosphodiesterase (PDE IV) inhibitors is described. The PDE IV inhibitor…”
Get full text
Journal Article -
16
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist
Published in Journal of medicinal chemistry (30-11-2006)“…Genetic manipulation studies in mice at both the MCH receptor 1 (MCHR1) as well as the MCH peptide levels have implicated MCHR1 as a key player in energy…”
Get full text
Journal Article -
17
-
18
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium
Published in Anesthesiology (Philadelphia) (01-04-2004)“…No replacement for succinylcholine is yet available. GW280430A (AV430A) is a representative of a new class of nondepolarizing neuromuscular blocking drugs…”
Get full text
Journal Article -
19
CNS 7056
Published in Anesthesiology (Philadelphia) (01-07-2007)“…Abstract Background: A new benzodiazepine derivative, CNS 7056, has been developed to permit a superior sedative profile to current agents, i.e., more…”
Get full text
Journal Article -
20
Identification and Structure–Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists
Published in Bioorganic & medicinal chemistry letters (04-11-2002)“…The synthesis and evaluation of novel ultrashort-acting benzodiazepine (USA BZD) agonists are described. A BZD scaffold was modified by incorporation of amino…”
Get full text
Journal Article